Compounded medications should come with receipts. Here is how certificates of analysis and stability studies work — and a current sample from the licensed pharmacy network that fills Peptivik prescriptions.
Sampled from the dispensing network’s published COA library on September 21, 2026. Lots rotate as batches are produced and dispensed — these are examples of the documentation standard, not an inventory list, and not a claim about which lot fills a given prescription. PT-141, the newest addition to our lineup, is not yet listed in the network’s published library; its lots will appear here when the pharmacy publishes them.
| Lot | Strength | Vial | Expires | Compounding pharmacy |
|---|---|---|---|---|
| PGR-05062026-01 | 18 mg/mL | 4 mL | Dec 2, 2026 | PGRrx |
| AP-202644 | 18 mg/mL | 2 mL | Nov 26, 2026 | Apothecary |
| HT-19 | 72 mg | 4 mL | May 2, 2027 | Hyalo Technologies |
| Lot | Strength | Vial | Expires | Compounding pharmacy |
|---|---|---|---|---|
| HT-14 | 2.5 mg / 0.5 mg (with B12) | 5 mL | Apr 15, 2027 | Hyalo Technologies |
| HT-16 | 2.5 mg / 5 mg (with glycine) | 5 mL | Apr 13, 2027 | Hyalo Technologies |
| Lot | Strength | Vial | Expires | Compounding pharmacy |
|---|---|---|---|---|
| ProRx04132026@2 | 15 mg / 6 mL | 6 mL | Nov 9, 2026 | ProRx |
| Lot | Strength | Vial | Expires | Compounding pharmacy |
|---|---|---|---|---|
| ProRx04142026@1 | 200 mg/mL | 10 mL | Oct 11, 2026 | ProRx |
| Lot | Strength | Vial | Expires | Compounding pharmacy |
|---|---|---|---|---|
| 26.03.00000034 | 200 mg/mL | 6 mL | Oct 4, 2026 | Annovex |
| 26.05.00000018 | 200 mg/mL | 6 mL | Nov 15, 2026 | Annovex |
The network also publishes temperature-excursion studies — measured answers to what happens if a shipment spends time outside refrigeration. Published findings, as stated by the testing pharmacies:
| Study | Published finding | Dated |
|---|---|---|
| Tirzepatide — room temperature | Stable for 4 days at ambient temperature. | Mar 2026 |
| Tirzepatide — elevated temperature | Stable for 2 days at 40°C (104°F) — studied by two independent compounders. | May 2026 |
| Tirzepatide & semaglutide co-formulations (Hyalo) | Stable for 4 days at 60°C (140°F). | 2026–2027 lots |
| Semaglutide/glycine — temperature excursion, 0–60°C | Minor degradation observed only at 60°C by day 4. | Aug 2025 |
Excursion studies describe tested shipping scenarios — they are not storage instructions. Always follow the storage and handling directions on your medication label.
Every vial dispensed to you carries a lot number on its label. Email it to support@peptivik.com and we’ll request the certificate of analysis for that exact lot from the dispensing pharmacy.
Prescriptions through Peptivik are filled by state-licensed compounding pharmacies in our medical partner’s dispensing network; the pharmacy that fills a given prescription varies by state and product. Certificates of analysis and stability studies are documents produced and published by those pharmacies and their testing partners, reproduced here for education — Peptivik does not manufacture, compound, test, or handle medication. This page is educational and is not medical advice.